Financials

News Ideas Technicals

42C fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to IX BIOPHARMA operating, investing, and financing activities

42C free cash flow for H1 24 is -3.28 M SGD. For 2023, 42C free cash flow was -8.63 M SGD and operating cash flow was -7.93 M SGD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SGD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—